Sun et al. confirmed metformin acted in part through a Bacteroides fragilis – the bile acid glycoursodeoxycholic acid (GUDCA) – intestinal farnesoid X receptor (FXR) axis to improve metabolic dysfunction, including hyperglycemia (Mariño et al., 2017). This evidence concerns the gene NR1H4 and Hyperglycemia.